These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2545766)

  • 1. Effects of the opiate agonist loperamide on pituitary-adrenal function in patients with suspected hypercortisolism.
    Ambrosi B; Bochicchio D; Ferrario R; Colombo P; Faglia G
    J Endocrinol Invest; 1989 Jan; 12(1):31-5. PubMed ID: 2545766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between the suppressive effects of dexamethasone and loperamide on cortisol and ACTH secretion in some pathological conditions.
    Bernini GP; Argenio GF; Cerri F; Franchi F
    J Endocrinol Invest; 1994 Nov; 17(10):799-804. PubMed ID: 7699214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of loperamide on the human hypothalamo-pituitary-adrenal axis in vivo and in vitro.
    Auernhammer CJ; Stalla GK; Lange M; Pfeiffer A; Müller OA
    J Clin Endocrinol Metab; 1992 Aug; 75(2):552-7. PubMed ID: 1322429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cushing's syndrome: diagnostic exploration].
    Tabarin A; Roger P
    Presse Med; 1994 Jan 8-15; 23(1):43-8. PubMed ID: 8127815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
    J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Aron DC; Raff H; Findling JW
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1780-5. PubMed ID: 9177382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loperamide test: a simple and highly specific screening test for hypercortisolism in children and adolescents.
    Buzi F; Corna A; Pilotta A; Negrini F; Lombardi A; Re T; Ambrosi B
    Acta Paediatr; 1997 Nov; 86(11):1177-80. PubMed ID: 9401509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
    Reincke M; Allolio B; Würth G; Winkelmann W
    J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In man the mu-opiate agonist loperamide specifically inhibits ACTH secretion induced by the cholecystokinin-like peptide ceruletide.
    Auernhammer CJ; Riepl RL; Schopohl J; Lehnert P; Müller OA; Stalla GK
    Neuroendocrinology; 1994 Jul; 60(1):16-22. PubMed ID: 8090278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion.
    Ambrosi B; Bochicchio D; Fadin C; Colombo P; Faglia G
    J Endocrinol Invest; 1990 Mar; 13(3):257-61. PubMed ID: 1973178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressibility of plasma adrenocorticotropin by hydrocortisone: potential usefulness in the diagnosis of Cushing's disease.
    Streeten DH; Anderson GH; Brennan S; Jones C
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1114-20. PubMed ID: 9543127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of carbamazepine on pituitary-adrenal function in healthy volunteers.
    Perini GI; Devinsky O; Hauser P; Gallucci WT; Theodore WH; Chrousos GP; Gold PW; Kling MA
    J Clin Endocrinol Metab; 1992 Feb; 74(2):406-12. PubMed ID: 1309836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loperamide, an opiate analogue, inhibits plasma ACTH levels in patients with Addison's disease.
    Ambrosi B; Bochicchio D; Faglia G
    Clin Endocrinol (Oxf); 1986 May; 24(5):483-9. PubMed ID: 3024866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
    JAMA; 1993 May; 269(17):2232-8. PubMed ID: 8386285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: early recognition of the occult ectopic ACTH syndrome.
    Findling JW; Kehoe ME; Shaker JL; Raff H
    J Clin Endocrinol Metab; 1991 Aug; 73(2):408-13. PubMed ID: 1649842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
    Gold PW; Kling MA; Khan I; Calabrese JR; Kalogeras K; Post RM; Avgerinos PC; Loriaux DL; Chrousos GP
    Adv Biochem Psychopharmacol; 1987; 43():183-200. PubMed ID: 3035886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic-pituitary-adrenal axis in corticosteroid-resistant bronchial asthma.
    Lane SJ; Atkinson BA; Swaminathan R; Lee TH
    Am J Respir Crit Care Med; 1996 Feb; 153(2):557-60. PubMed ID: 8564097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pioglitazone on adrenocorticotropic hormone and cortisol secretion in Cushing's disease.
    Suri D; Weiss RE
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1340-6. PubMed ID: 15585550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary cortisol measurement: a practical approach to assess pituitary-adrenal function.
    Laudat MH; Cerdas S; Fournier C; Guiban D; Guilhaume B; Luton JP
    J Clin Endocrinol Metab; 1988 Feb; 66(2):343-8. PubMed ID: 2828410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
    Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.